With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results